Hepion Pharmaceuticals Inc.
07/02/2026 | Press release | Distributed by Public on 07/02/2026 14:32
Management Change/Compensation (Form 8-K)
| Item 5.02 | Departure of Directors or Certain Officers: Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On July 1, 2026, the Board of Directors of Hepion Pharmaceuticals, Inc. (the "Company") approved the appointment of Danina Fisher and Gary S. Stetz, II as directors of the Company, effective immediately.
There are no arrangements or understandings between Ms. Fisher and Mr. Stetz and any other person pursuant to which such person was selected as a director of the Company, and there is no family relationship between any of Ms. Fisher and Mr. Stetz, except that Mr. Stetz is Gary Stetz's son.
Hepion Pharmaceuticals Inc. published this content on July 02, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 02, 2026 at 20:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]